The U.S. Food and Drug Administration for the first time approved a vaccine that protects against the deadly Ebola virus.
The vaccine, Ervebo, is for the prevention of Ebola virus disease caused by Zaire ebolavirus in people 18 and older, the agency said Thursday.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
